LISTEN
Schultz: Businesses need to do more to help people
Yahoo Finance's Julia La Roche sits down with executive chairman and former CEO of Starbucks Howard Schultz
| Previous Close | 93.42 |
| Open | 93.18 |
| Bid | 83.50 x 100 |
| Ask | 95.83 x 100 |
| Day's Range | 92.66 - 95.02 |
| 52 Week Range | 78.42 - 100.51 |
| Volume | 1,065,389 |
| Avg. Volume | 1,385,315 |
| Market Cap | 16.64B |
| Beta | 1.85 |
| PE Ratio (TTM) | -88.41 |
| EPS (TTM) | -1.07 |
| Earnings Date | Oct 25, 2017 - Oct 30, 2017 |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 111.57 |
- Zacks•2 days ago
Biotech Stock Roundup: FDA Nod for First Cancer Biosimilar, HALO up on Deals, Raised Outlook
Data presentations, regulatory updates and licensing deals were among the key highlights this week with the focus being on the FDA approval of the first cancer biosimilar - Amgen's (AMGN) Mvasi.
- Zacks•4 days ago
BioMarin Says FDA Not Planning an AdCom for Pegvaliase BLA
The FDA currently shows no intent to hold an AdCom to discuss the BLA for BioMarin's (BMRN) pipeline candidate, pegvaliase.
- Motley Fool•4 days ago
Billionaire George Soros' Fund Bought These 3 Pharma Stocks: Should You?
These three orphan drugmakers were on Soros' radar last quarter.
